© 2026, NOVARHYTHM BIOSCIENCES.
SAR 29789871 represents a De-Risked, Mechanism-Driven Opportunity in a Major Cardiovascular Market.
NovaRhythm is actively engaging with strategic partners, investors, and clinical collaborators who share our commitment to transforming care in cardiac arrhythmias, in particular atrial fibrillation.
NovaRhythm provides its investor deck and related materials upon request.
Please complete the form below to request access. A member of the NovaRhythm team will follow up directly.